Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathy.

MLA

Zuppa, Angela, et al. “Maintenance Treatment with Subcutaneous Immunoglobulins in the Long-Term Management of Anti-HMCGR Myopathy.” Neuromuscular Disorders, vol. 31, no. 2, Feb. 2021, pp. 134–38. EBSCOhost, https://doi.org/10.1016/j.nmd.2020.12.012.

APA

Zuppa, A., De Michelis, C., Meo, G., Prada, V., Gemelli, C., Infantino, M., Manfredi, M., Pesce, G., Tagliafico, A. S., Benedetti, L., Fiorillo, C., Schenone, A., Quartuccio, L., & Grandis, M. (2021). Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathy. Neuromuscular Disorders, 31(2), 134–138. https://doi.org/10.1016/j.nmd.2020.12.012

Chicago

Zuppa, Angela, Chiara De Michelis, Giuseppe Meo, Valeria Prada, Chiara Gemelli, Maria Infantino, Mariangela Manfredi, et al. 2021. “Maintenance Treatment with Subcutaneous Immunoglobulins in the Long-Term Management of Anti-HMCGR Myopathy.” Neuromuscular Disorders 31 (2): 134–38. doi:10.1016/j.nmd.2020.12.012.